Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study.
Details
Serval ID
serval:BIB_82F14C0B109A
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study.
Journal
The Lancet. Child & adolescent health
Working group(s)
EUCLIDS Consortium
Contributor(s)
Levin M., Coin L., Gormley S., Hamilton S., Herberg J., Hourmat B., Hoggart C., Kaforou M., Sancho-Shimizu V., Wright V., Abdulla A., Agapow P., Bartlett M., Bellos E., Eleftherohorinou H., Galassini R., Inwald D., Mashbat M., Menikou S., Mustafa S., Nadel S., Rahman R., Thakker C., Bokhandi S., Power S., Barham H., Pathan N., Ridout J., White D., Thurston S., Faust S., Patel S., McCorkell J., Davies P., Crate L., Navarra H., Carter S., Ramaiah R., Patel R., Tuffrey C., Gribbin A., McCready S., Peters M., Hardy K., Standing F., O'Neill L., Abelake E., Deep A., Nsirim E., Pollard A., Willis L., Young Z., Royad C., White S., Fortune P.M., Hudnott P., Martinón-Torres F., Salas Ellacuriaga A., Álvez González F., Barral-Arca R., Cebey-López M., Curras-Tuala M.J., García N., García Vicente L., Gómez-Carballa A., Gómez Rial J., Grela Beiroa A., Justicia Grande A., Leboráns Iglesias P., Martínez Santos A.E., Martinón-Torres N., Martinón Sánchez J.M., Morillo Gutiérrez B., Mosquera Pérez B., Obando Pacheco P., Pardo-Seco J., Pischedda S., Rivero-Calle I., Rodríguez-Tenreiro C., Redondo-Collazo L., Serén Fernández S., Porto Silva MDS, Vega A., Vilanova Trillo L., Reyes S.B., León León M.C., Navarro Mingorance Á., Gabaldó Barrios X., Oñate Vergara E., Concha Torre A., Vivanco A., Fernández R., Giménez Sánchez F., Sánchez Forte M., Rojo P., Ruiz Contreras J., Palacios A., Epalza Ibarrondo C., Fernández Cooke E., Navarro M., Álvarez Álvarez C., Lozano M.J., Carreras E., Brió Sanagustín S., Neth O., Martínez Padilla MDC, Prieto Tato L.M., Guillén S., Fernández Silveira L., Moreno D., de Groot R., van Furth A.M., van der Flier M., Boeddha N.P., Driessen G.J., Emonts M., Hazelzet J.A., Kuijpers T.W., Pajkrt D., Sanders E.A., van de Beek D., van der Ende A., Philipsen R., Adeel A.O., Breukels M.A., Brinkman D.M., de Korte C.C., de Vries E., de Waal W.J., Dekkers R., Dings-Lammertink A., Doedens R.A., Donker A.E., Dousma M., Faber T.E., Gerrits GPJ, Gerver J.A., Heidema J., Homan-van der Veen J., Jacobs M.A., Jansen N.J., Kawczynski P., Klucovska K., Kneyber M.C., Koopman-Keemink Y., Langenhorst V.J., Leusink J., Loza B.F., Merth I.T., Miedema C.J., Neeleman C., Noordzij J.G., Obihara C.C., van Overbeek-van Gils ALT, Poortman G.H., Potgieter S.T., Potjewijd J., Rosias P.P., Sprong T., Ten Tussher G.W., Thio B.J., Tramper-Stranders G.A., van Deuren M., van der Meer H., van Kuppevelt A.J., van Wermeskerken A.M., Verwijs W.A., Wolfs T.F., Schlapbach L.J., Agyeman P., Aebi C., Berger C., Giannoni E., Stocker M., Posfay-Barbe K.M., Heininger U., Bernhard-Stirnemann S., Niederer-Loher A., Kahlert C., Hasters P., Relly C., Baer W., Berger C., Carrol E., Paulus S., Frederick H., Jennings R., Johnston J., Kenwright R., Fink C.G., Pinnock E., Emonts M., Agbeko R.S., Anderson S.T., Secka F., Bojang K.A., Sarr I., Kebbeh N., Sey G., Saidykhan M., Cole F., Thomas G., Antonio M., Zenz W., Klobassa D.S., Binder A., Schweintzger N.A., Sagmeister M., Baumgart H., Baumgartner M., Behrends U., Biebl A., Birnbacher R., Blanke J.G., Boelke C., Breuling K., Brunner J., Buller M., Dahlem P., Dietrich B., Eber E., Elias J., Emhofer J., Etschmaier R., Farr S., Girtler Y., Grigorow I., Heimann K., Ihm U., Jaros Z., Kalhoff H., Kaulfersch W., Kemen C., Klocker N., Köster B., Kohlmaier B., Komini E., Kramer L., Neubert A., Ortner D., Pescollderungg L., Pfurtscheller K., Reiter K., Ristic G., Rödl S., Sellner A., Sonnleitner A., Sperl M., Stelzl W., Till H., Trobisch A., Vierzig A., Vogel U., Weingarten C., Welke S., Wimmer A., Wintergerst U., Wüller D., Zaunschirm A., Ziuraite I., Žukovskaja V.
ISSN
2352-4650 (Electronic)
ISSN-L
2352-4642
Publication state
Published
Issued date
06/2018
Peer-reviewed
Oui
Volume
2
Number
6
Pages
404-414
Language
english
Notes
Publication types: Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Abstract
Sepsis and severe focal infections represent a substantial disease burden in children admitted to hospital. We aimed to understand the burden of disease and outcomes in children with life-threatening bacterial infections in Europe.
The European Union Childhood Life-threatening Infectious Disease Study (EUCLIDS) was a prospective, multicentre, cohort study done in six countries in Europe. Patients aged 1 month to 18 years with sepsis (or suspected sepsis) or severe focal infections, admitted to 98 participating hospitals in the UK, Austria, Germany, Lithuania, Spain, and the Netherlands were prospectively recruited between July 1, 2012, and Dec 31, 2015. To assess disease burden and outcomes, we collected demographic and clinical data using a secured web-based platform and obtained microbiological data using locally available clinical diagnostic procedures.
2844 patients were recruited and included in the analysis. 1512 (53·2%) of 2841 patients were male and median age was 39·1 months (IQR 12·4-93·9). 1229 (43·2%) patients had sepsis and 1615 (56·8%) had severe focal infections. Patients diagnosed with sepsis had a median age of 27·6 months (IQR 9·0-80·2), whereas those diagnosed with severe focal infections had a median age of 46·5 months (15·8-100·4; p<0·0001). Of 2844 patients in the entire cohort, the main clinical syndromes were pneumonia (511 [18·0%] patients), CNS infection (469 [16·5%]), and skin and soft tissue infection (247 [8·7%]). The causal microorganism was identified in 1359 (47·8%) children, with the most prevalent ones being Neisseria meningitidis (in 259 [9·1%] patients), followed by Staphylococcus aureus (in 222 [7·8%]), Streptococcus pneumoniae (in 219 [7·7%]), and group A streptococcus (in 162 [5·7%]). 1070 (37·6%) patients required admission to a paediatric intensive care unit. Of 2469 patients with outcome data, 57 (2·2%) deaths occurred: seven were in patients with severe focal infections and 50 in those with sepsis.
Mortality in children admitted to hospital for sepsis or severe focal infections is low in Europe. The disease burden is mainly in children younger than 5 years and is largely due to vaccine-preventable meningococcal and pneumococcal infections. Despite the availability and application of clinical procedures for microbiological diagnosis, the causative organism remained unidentified in approximately 50% of patients.
European Union's Seventh Framework programme.
The European Union Childhood Life-threatening Infectious Disease Study (EUCLIDS) was a prospective, multicentre, cohort study done in six countries in Europe. Patients aged 1 month to 18 years with sepsis (or suspected sepsis) or severe focal infections, admitted to 98 participating hospitals in the UK, Austria, Germany, Lithuania, Spain, and the Netherlands were prospectively recruited between July 1, 2012, and Dec 31, 2015. To assess disease burden and outcomes, we collected demographic and clinical data using a secured web-based platform and obtained microbiological data using locally available clinical diagnostic procedures.
2844 patients were recruited and included in the analysis. 1512 (53·2%) of 2841 patients were male and median age was 39·1 months (IQR 12·4-93·9). 1229 (43·2%) patients had sepsis and 1615 (56·8%) had severe focal infections. Patients diagnosed with sepsis had a median age of 27·6 months (IQR 9·0-80·2), whereas those diagnosed with severe focal infections had a median age of 46·5 months (15·8-100·4; p<0·0001). Of 2844 patients in the entire cohort, the main clinical syndromes were pneumonia (511 [18·0%] patients), CNS infection (469 [16·5%]), and skin and soft tissue infection (247 [8·7%]). The causal microorganism was identified in 1359 (47·8%) children, with the most prevalent ones being Neisseria meningitidis (in 259 [9·1%] patients), followed by Staphylococcus aureus (in 222 [7·8%]), Streptococcus pneumoniae (in 219 [7·7%]), and group A streptococcus (in 162 [5·7%]). 1070 (37·6%) patients required admission to a paediatric intensive care unit. Of 2469 patients with outcome data, 57 (2·2%) deaths occurred: seven were in patients with severe focal infections and 50 in those with sepsis.
Mortality in children admitted to hospital for sepsis or severe focal infections is low in Europe. The disease burden is mainly in children younger than 5 years and is largely due to vaccine-preventable meningococcal and pneumococcal infections. Despite the availability and application of clinical procedures for microbiological diagnosis, the causative organism remained unidentified in approximately 50% of patients.
European Union's Seventh Framework programme.
Keywords
Algorithms, Bacterial Infections/epidemiology, Child, Preschool, Cohort Studies, Cost of Illness, Europe/epidemiology, Female, Humans, Infant, Infant, Newborn, Male, Prospective Studies, Sepsis/epidemiology, Severity of Illness Index
Pubmed
Web of science
Publisher's website
Create date
01/07/2021 10:42
Last modification date
30/10/2024 7:18
Usage data
